MARKET

HUMA

HUMA

Humacyte Inc
NASDAQ
1.190
-0.020
-1.65%
After Hours: 1.210 +0.02 +1.68% 19:55 05/09 EDT
OPEN
1.240
PREV CLOSE
1.210
HIGH
1.250
LOW
1.180
VOLUME
2.02M
TURNOVER
--
52 WEEK HIGH
9.97
52 WEEK LOW
1.150
MARKET CAP
184.59M
P/E (TTM)
-0.9481
1D
5D
1M
3M
1Y
5Y
1D
HUMACYTE TO PRESENT FIRST QUARTER FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE ON MAY 13, 2025
Reuters · 1d ago
Largest borrow rate increases among liquid names
TipRanks · 4d ago
Weekly Report: what happened at HUMA last week (0428-0502)?
Weekly Report · 6d ago
All You Need to Know About Humacyte, Inc. (HUMA) Rating Upgrade to Buy
NASDAQ · 04/30 16:00
Weekly Report: what happened at HUMA last week (0421-0425)?
Weekly Report · 04/28 09:23
Humacyte, Inc. (NASDAQ:HUMA): Is Breakeven Near?
Simply Wall St · 04/25 11:51
Weekly Report: what happened at HUMA last week (0414-0418)?
Weekly Report · 04/21 09:23
Humacyte Challenges FDA Petition Amidst Controversy
TipRanks · 04/18 10:29
More
About HUMA
More
Humacyte, Inc. is a commercial-stage biotechnology platform company. The Company is engaged in developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a range of diseases, injuries, and chronic conditions. It is using its proprietary, scientific technology platform to engineer and manufacture acellular tissue engineered vessels (ATEVs). The Company is also in late-stage clinical trials targeting other vascular applications, including arteriovenous (AV) access for hemodialysis and peripheral artery disease (PAD). The Company is also engaged in the preclinical development of coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple cell and tissue applications.
Recently
Symbol
Price
%Change

Webull offers Humacyte Inc stock information, including NASDAQ: HUMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HUMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HUMA stock methods without spending real money on the virtual paper trading platform.